Skip to main content
Premium Trial:

Request an Annual Quote

Centogene MOx 2.0

Centogene has launched an expanded version of MOx, the company's multiomic diagnostic portfolio, which now includes transcriptome analysis. The new version, MOx 2.0, combines whole-genome or whole-exome sequencing, biochemical testing, and RNA sequencing. According to the company, the integration of RNA sequencing provides a more complete picture of a patient's disease biology and drug response.